NASDAQ:RANI

Rani Therapeutics Holdings Stock Predictions

etoro logo Buy RANI
*Your capital is at risk
$0.88
+0.0174 (+2.03%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

RANI Prediction Chart

RANI Predictions History

Latest community submissions for RANI.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 27, 2026 $1.11 +3.20% $0.81 X 62.50% 0
Mar 27, 2026 $1.10 +2.00% $0.81 X 64.10% 0
Mar 27, 2026 Bullish $0.81 X 0
Nov 11, 2025 $2.03 +9.15% $1.94 V 95.35% 1
Nov 11, 2025 $1.97 +5.72% $1.94 V 98.64% 2
Nov 11, 2025 Bullish $1.94 X 1
Oct 24, 2025 Bullish $1.82 X 0
Oct 20, 2025 $1.57 -3.98% $2.25 X 69.99% 0
Oct 20, 2025 $1.60 -2.49% $2.25 X 71.07% 0
Oct 20, 2025 Bullish $2.25 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for RANI with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT RANI THERAPEUTICS HOLDINGS, INC.
Rani Therapeutics Holdings
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-al...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE